Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | COLL | SAVA | ||
| Company | Enliven Therapeutics Inc | Collegium Pharma | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.38 | 32.64 | 22.74 | ||
| High | 23.42 | 33.50 | 22.90 | ||
| Low | 21.91 | 32.26 | 21.55 | ||
| Last | 22.57 | 33.14 | 22.03 | ||
| Change | +0.03 | +0.71 | -0.42 | ||
| % Change | +0.13% | +2.19% | -1.87% | ||
| Volume | 285,900 | 566,500 | 598,900 | ||
| 20-Day Average Volume | 349,600 | 557,145 | 713,975 | ||
| Previous Close | 22.54 | 32.43 | 22.45 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.38 | 34.44 | 21.87 | ||
| 20-Day Raw Stochastic | 34.97% | 33.25% | 50.12% | ||
| 20-Day Relative Strength | 54.28% | 43.24% | 50.73% | ||
| Weighted Alpha | -19.72 | +45.70 | -15.42 | ||
| Today's Opinion | 80% Buy | 8% Buy | 16% Buy | ||
| Previous Opinion | 80% Buy | 8% Sell | 16% Buy | ||
| Last Month's Opinion | 88% Buy | 72% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.78% since 05/23/24 | -2.01% since 05/23/24 | +1.06% since 05/23/24 | ||
| Low | 21.18 on 05/29/24 | 32.08 on 05/30/24 | 21.15 on 05/28/24 | ||
| High | 24.34 on 05/28/24 | 34.55 on 05/24/24 | 22.90 on 05/31/24 | ||
| 1-Month | |||||
| %Chg | +29.79% since 04/30/24 | -10.26% since 04/30/24 | -0.54% since 04/30/24 | ||
| Low | 17.68 on 05/01/24 | 30.42 on 05/10/24 | 19.93 on 05/07/24 | ||
| High | 25.16 on 05/09/24 | 38.60 on 05/09/24 | 24.12 on 05/15/24 | ||
| 3-Month | |||||
| %Chg | +41.33% since 02/29/24 | -9.72% since 02/29/24 | -4.13% since 02/29/24 | ||
| Low | 10.90 on 03/15/24 | 30.42 on 05/10/24 | 18.18 on 03/11/24 | ||
| High | 26.00 on 04/11/24 | 40.95 on 03/28/24 | 26.68 on 04/11/24 | ||
| 6-Month | |||||
| %Chg | +89.82% since 11/29/23 | +29.50% since 11/29/23 | +7.25% since 11/29/23 | ||
| Low | 9.80 on 12/12/23 | 25.21 on 12/04/23 | 18.18 on 03/11/24 | ||
| High | 26.00 on 04/11/24 | 40.95 on 03/28/24 | 32.10 on 12/12/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,061,625 | 1,084,175 | 1,056,911 | ||
| Shares Outstanding, K | 47,037 | 32,715 | 47,976 | ||
| Annual Sales | 0 | 566,770,000 | 0 | ||
| Annual Net Income | -71,580,000 | 48,160,000 | -97,220,000 | ||
| Last Quarter Sales | 0 | 144,920,000 | 0 | ||
| Last Quarter Net Income | -22,740,000 | 27,710,000 | 25,040,000 | ||
| 60-Month Beta | 1.05 | 1.06 | -0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/14/24 | 1.45 on 05/09/24 | -1.41 on 05/10/24 | ||
| Latest Earnings Date | 05/16/24 | 05/09/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.35 | 0.00 | ||